H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $12 to $30
Annexon Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Annexon Analyst Ratings
Annexon Biosciences' ANX005: Strong Buy Rating Backed by Promising Efficacy and Sales Potential
Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Mirum Pharmaceuticals (MIRM)
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $14 to $30
Annexon Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Annexon Analyst Ratings
Annexon Biosciences: Buy Rating Backed by Promising Data Releases and Strategic Long-term Potential
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
TD Cowen Reaffirms Their Buy Rating on Annexon Biosciences (ANNX)
Wells Fargo Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $14
Buy Rating Affirmed for Annexon Biosciences Amidst Promising Clinical Developments and Market Potential
Annexon Analyst Ratings
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $14 to $30